These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8548946)

  • 1. Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis.
    Howell R; Dowsett M; King N; Edmonds DK
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):609-15. PubMed ID: 8548946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Howell R; Edmonds DK; Dowsett M; Crook D; Lees B; Stevenson JC
    Fertil Steril; 1995 Sep; 64(3):474-81. PubMed ID: 7641897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].
    Wang YQ; Zhang SF; Chen X; Zhu J; Hua KQ; Hu WG
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):504-8. PubMed ID: 19957549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-back therapy in the treatment of endometriosis: the European experience.
    Edmonds DK
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():10-3. PubMed ID: 8916980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic exposure to a gonadotrophin-releasing hormone agonist on in vitro responsiveness of ovine pituitary cells to inhibin, activin and oestradiol.
    Muttukrishna S; Knight PG
    J Endocrinol; 1994 Mar; 140(3):483-93. PubMed ID: 8182376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
    Maouris P; Dowsett M; Rose G; Edmonds DK; Rothwell C; Robertson WR
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
    Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
    Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
    Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids.
    Burger HG; Hee JP; Mamers P; Bangah M; Zissimos M; McCloud PI
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):771-7. PubMed ID: 7889613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting gonadotrophin releasing hormone agonist implant causes variable duration of suppression of ovarian steroid and inhibin secretion.
    Fraser HM; Haining R; Cowen GM; Sandow J; Smith KB; Smith SK
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):97-104. PubMed ID: 1559303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
    Larsson-Cohn U; Johansson ED; Kågedal B; Wallentin L
    Br J Obstet Gynaecol; 1978 May; 85(5):367-72. PubMed ID: 646971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J; Banah M; McCloud P; Hee J; Burger H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can hormone replacement therapy be used during medical therapy of endometriosis?
    Edmonds DK; Howell R
    Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():24-6. PubMed ID: 8199100
    [No Abstract]   [Full Text] [Related]  

  • 17. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial.
    Gong L; Zhang S; Han Y; Long Q; Zou S; Cao Y
    J Clin Pharmacol; 2015 Aug; 55(8):848-53. PubMed ID: 25694383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative to hysterectomy? GnRH analogue combined with hormone replacement therapy.
    Gangar KF; Stones RW; Saunders D; Rogers V; Rae T; Cooper S; Beard RW
    Br J Obstet Gynaecol; 1993 Apr; 100(4):360-4. PubMed ID: 8494837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced sensitivity to steroid-negative feedback during breast-feeding: low-dose estradiol (transdermal estradiol supplementation) suppresses gonadotropins and ovarian activity assessed by inhibin B.
    Perheentupa A; Critchley HO; Illingworth PJ; McNeilly AS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4280-6. PubMed ID: 11095468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.